NCT02891629View on ClinicalTrials.gov

Safety and Feasibility of the EyeControl Device

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

January 28, 2017

Study Completion Date

February 28, 2017

Conditions
ALS (Amyotrophic Lateral Sclerosis)
Interventions
DEVICE

EyeControl device

Use of device features including control of gestures, use of menus, activation of pre- defined modes and writing full sentences

All Listed Sponsors
lead

Eyefree Assisting Communication Ltd

INDUSTRY

NCT02891629 - Safety and Feasibility of the EyeControl Device | Biotech Hunter | Biotech Hunter